The role of PGE2 as a pro-inflammatory agent was confirmed in vivo in models of contact hypersensitivity, IBD, RA and EAE, with EP4 identified as the major mediator leading to Th1/Th17 differentiation [32, 38, 47, 59–61]. This evidence concerns the gene PTGER4 and inflammatory bowel disease.